R L Hintz

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi request reprint Final height prediction in constitutional growth delay
    R L Hintz
    Department of Pediatrics, Stanford University School of Medicine, CA 94305 520, USA
    J Pediatr Endocrinol Metab 14:1535-40. 2001
  2. ncbi request reprint Growth hormone treatment of idiopathic short stature: clinical studies
    Raymond L Hintz
    Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305, USA
    Growth Horm IGF Res 15:S6-8. 2005
  3. ncbi request reprint Confirming the diagnosis of growth hormone deficiency (GHD) and transitioning the care of patients with childhood-onset GHD
    Raymond L Hintz
    Department of Pediatrics, Stanford University, Stanford, CA 94305, USA
    J Pediatr Endocrinol Metab 16:631-5. 2003
  4. ncbi request reprint SHOX mutations
    Raymond L Hintz
    Department of Pediatrics, Stanford University School of Medicine, CA 94305, USA
    Rev Endocr Metab Disord 3:363-7. 2002
  5. ncbi request reprint Functional consequences of the somatopause and its treatment
    A R Hoffman
    GRECC and Medical Service, VA Palo Alto Health Care System, Palo Alto, CA, USA
    Endocrine 7:73-6. 1997
  6. ncbi request reprint Diabetes mellitus and profound insulin resistance in Johanson-Blizzard syndrome
    W J Steinbach
    Department of Pediatrics, Lucile Packard Children s Hospital at Stanford University, California, USA
    J Pediatr Endocrinol Metab 13:1633-6. 2000
  7. ncbi request reprint The insulin-like growth factor axis and growth in children with chronic renal failure: a report of the Southwest Pediatric Nephrology Study Group
    D R Powell
    Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, USA
    J Clin Endocrinol Metab 83:1654-61. 1998
  8. ncbi request reprint A sensitive radioimmunoassay for somatomedin-C/insulin-like growth-factor I based on synthetic insulin-like growth factor 57-70
    R L Hintz
    Department of Pediatrics, Stanford University
    Horm Metab Res 20:344-7. 1988
  9. ncbi request reprint Diagnosis and management of growth hormone deficiency in childhood and adolescence--part 2: growth hormone treatment in growth hormone deficient children
    Toshiaki Tanaka
    Department of Endocrinology and Metabolism, National Children s Medical Research Center, Tokyo, Japan
    Growth Horm IGF Res 12:323-41. 2002
  10. ncbi request reprint IGF-I does not affect the net increase in GH release in response to arginine
    Ralf Nass
    Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia, Charlottesville, Virginia 22908, USA
    Am J Physiol Endocrinol Metab 283:E702-10. 2002

Detail Information

Publications11

  1. ncbi request reprint Final height prediction in constitutional growth delay
    R L Hintz
    Department of Pediatrics, Stanford University School of Medicine, CA 94305 520, USA
    J Pediatr Endocrinol Metab 14:1535-40. 2001
    ..This article reviews the methods of height prediction that are available, and their limitations...
  2. ncbi request reprint Growth hormone treatment of idiopathic short stature: clinical studies
    Raymond L Hintz
    Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305, USA
    Growth Horm IGF Res 15:S6-8. 2005
    ..Still, the availability of GH for this patient population provides a rational treatment option for patients who fail arbitrary and inaccurate assessments...
  3. ncbi request reprint Confirming the diagnosis of growth hormone deficiency (GHD) and transitioning the care of patients with childhood-onset GHD
    Raymond L Hintz
    Department of Pediatrics, Stanford University, Stanford, CA 94305, USA
    J Pediatr Endocrinol Metab 16:631-5. 2003
    ..The patient's transition to GH replacement in adulthood should be arranged as a close collaboration between the pediatric and adult endocrinologists, who should discuss the reinitiation of treatment with the patient...
  4. ncbi request reprint SHOX mutations
    Raymond L Hintz
    Department of Pediatrics, Stanford University School of Medicine, CA 94305, USA
    Rev Endocr Metab Disord 3:363-7. 2002
  5. ncbi request reprint Functional consequences of the somatopause and its treatment
    A R Hoffman
    GRECC and Medical Service, VA Palo Alto Health Care System, Palo Alto, CA, USA
    Endocrine 7:73-6. 1997
    ..Moreover, it is clear that both hormones can cause significant morbidity...
  6. ncbi request reprint Diabetes mellitus and profound insulin resistance in Johanson-Blizzard syndrome
    W J Steinbach
    Department of Pediatrics, Lucile Packard Children s Hospital at Stanford University, California, USA
    J Pediatr Endocrinol Metab 13:1633-6. 2000
    ..We report a patient with JBS and new-onset diabetes mellitus with profound insulin resistance, with no clinical or laboratory evidence of pancreatic exocrine insufficiency...
  7. ncbi request reprint The insulin-like growth factor axis and growth in children with chronic renal failure: a report of the Southwest Pediatric Nephrology Study Group
    D R Powell
    Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, USA
    J Clin Endocrinol Metab 83:1654-61. 1998
    ....
  8. ncbi request reprint A sensitive radioimmunoassay for somatomedin-C/insulin-like growth-factor I based on synthetic insulin-like growth factor 57-70
    R L Hintz
    Department of Pediatrics, Stanford University
    Horm Metab Res 20:344-7. 1988
    ....
  9. ncbi request reprint Diagnosis and management of growth hormone deficiency in childhood and adolescence--part 2: growth hormone treatment in growth hormone deficient children
    Toshiaki Tanaka
    Department of Endocrinology and Metabolism, National Children s Medical Research Center, Tokyo, Japan
    Growth Horm IGF Res 12:323-41. 2002
  10. ncbi request reprint IGF-I does not affect the net increase in GH release in response to arginine
    Ralf Nass
    Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia, Charlottesville, Virginia 22908, USA
    Am J Physiol Endocrinol Metab 283:E702-10. 2002
    ..These findings suggest that the negative feedback effect of IGF-I on GH secretion is primarily mediated at the pituitary level and/or at the hypothalamus through a mechanism different from the stimulatory effect of arginine...
  11. pmc Growth hormone: uses and abuses
    Raymond L Hintz
    BMJ 328:907-8. 2004